• Home
  • Search Results

Search Results

Adult (35-64)
Cancer
419 studies match your search

Melanoma Margins Trial-II

The study aims at finding how much skin should be removed around the melanoma. Currently, doctors do not know how much skin to remove from around a melanoma to reduce the chances of the melanoma coming back. This study will help to learn if this approach is better or worse than the usual approach for melanoma surgery.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Melanoma)
Open

CIVO Intratumoral Microdosing of Anti-Cancer Therapies (Phase 0)

Do you have head and neck cancer or soft tissue sarcoma? Are you planning to have surgery to remove your tumor? You may be able to participate in a research study to determine which therapies may be best for future patients. Compensation provided.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Breast, Head and Neck, Melanoma, and 3 more)
Not currently enrolling

Entertainment media use among young adult cancer survivors

The purpose of this study is to better understand how young adults (ages 18 - 39) who have had cancer use entertainment media during and after cancer treatment.

Age & Gender
  • 18 years ~ 39 years
  • Male, Female, Gender Inclusive
Study Interest
  • Behavior
  • Cancer (Bladder, Brain and Other Nervous System, Breast, and 19 more)
  • Mental and Emotional Health
Visit Location
100% Remote (online, phone, text)

Sitting and Cardiovascular Disease Risk in Endometrial Cancer Survivors

This is a research study to find out which type of sedentary behavior, or sitting, is most strongly associated with cardiovascular disease (CVD) risk in endometrial cancer survivors. Additionally, we hope to better understand your perception of sedentary behavior and sedentary behavior reduction. The findings from this research study will be used to design a future sedentary behavior reduction intervention for endometrial cancer survivors. Participation in this study includes one assessment visit (during your regularly scheduled clinic visits) where we will measure your blood pressure and arterial stiffness using a blood-pressure like non-invasive device. Additionally, during this visit, you will answer questionnaires, complete a short physical function test (i.e., balance, walking, standing), and be instructed in how to use an accelerometer (movement tracking device worn on your upper thigh) paired with a smart-phone application that will ask you questions about your physical activities and sedentary behavior for 7-days following your

Age & Gender
  • 50 years ~ 80 years
  • Female
Study Interest
  • Cancer (Uterine (endometrial))
  • Women's Health
Open

Phase I Study of Autologous CAR-T Cells Targeting B7-H3 in Recurrent or Refractory GBM CAR.B7-H3 T c

Do you have glioblastoma? Has your cancer either come back or did not improve after the treatments you received? If so, you may be eligible to participate in this gene therapy research study that wants to learn if a new way to modify your immune cells for use as possible treatment is safe and at what dose.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Brain and Other Nervous System, Phase 1 Trials (all cancers))

Functional Needs for Newly Diagnosed Metastatic Breast Cancer

In this study, we want to use an online survey for people newly diagnosed with metastatic breast cancer to ask questions about physical and emotional health. We hope to use the results of this survey to design a program to help future patients tolerate treatment better.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Breast)
Open

A Study of DSP-5336 in Relapsed/Refractory AML/ ALL With or Without MLL Rearrangement or NPM1 Mutation

Have you been diagnosed with Leukemia and are looking for another treatment option? In this study we are looking to see if the study drug DSP-5336 can help control Leukemia or achieve remission.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Leukemia)
Open

Testing the Safety of the Anti-Cancer Drugs Durvalumab and Olaparib During Radiation Therapy for Locally Advanced Unresectable Pancreatic Cancer

Have you been diagnosed with advanced unresectable pancreatic cancer. If so, you may be able to take part in a research study looking at the safety and tolerability of olaparib in combination with durvalumab and radiation therapy in patients with pancreatic cancer.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Pancreatic)
Open

A phase II trial of induction and maintenance pembrolizumab and olaparib in locally advanced head and neck squamous cell carcinoma (HNSCC)

Have you been diagnosed with locally advanced head and neck squamous cell carcinoma? If so, you may be able to participate in a research study to evaluate whether pembrolizumab and olaparib given before and after chemoradiotherapy can improve 1-year progression free survival.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female
Study Interest
  • Cancer (Head and Neck)
Open

Impact of the Uterine and Gut Microbiomes in Endometrial Cancer Development and Treatment

Do you have a newly diagnosed endometrial cancer? if so, you may be eligible to participate in a research study looking at the role the uterine and gut microbiomes play in endometrial cancer development and treatment.

Age & Gender
  • 18 years ~ 99 years
  • Female
Study Interest
  • Cancer (Uterine (endometrial))
  • Microbiome
  • Women's Health
Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research